Publications by authors named "Xi-Yi Wei"
Background: According to current statistics, renal cancer accounts for 3% of all cancers worldwide. Renal cell carcinoma (RCC) is the most common solid lesion in the kidney and accounts for approximately 90% of all renal malignancies. Increasing evidence has shown an association between immune infiltration in RCC and clinical outcomes.
View Article and Find Full Text PDFArticle Synopsis
- * This study investigates how metabolic genes influence the prognosis, immune environment, and tumor growth in ccRCC, utilizing data from several medical databases.
- * A risk model was created based on four metabolic genes to predict ccRCC outcomes, and the study found that the gene PAFAH2 plays a role in inhibiting tumor cell growth and movement, potentially aiding in treatment strategies.